Google
FTRE — FORTREA HOLDINGS INC. (Healthcare >> Biotechnology)
FTRE FAQ
What is FTRE's ROE?
FORTREA HOLDINGS INC. reports a Return on Equity (ROE) of -84.98%.
What is FTRE's dividend yield?
FORTREA HOLDINGS INC. offers a dividend yield of 0.00%.
What is FTRE's Deepscope Quality Score?
Deepscope rates FTRE's overall financial quality at 46 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy FTRE?
Deepscope's AI Timing Score for FTRE is 87 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does FTRE belong to?
FORTREA HOLDINGS INC. is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange.
|
USD 17.40
Price
-0.12
(-0.68%)
Day Change
|
|
|---|
FTRE, the overall quality is not good ( Quality = 46) but the timing to buy is ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROE is relatively low.
ROA is relatively low.
Historical ROE is relatively low
Negative growth of ROE in the last year.
Growth of ROA was below our criteria in the last year.
Net profit margin is relatively low.
Historical net profit margin is relatively low.
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
In details, quality factors are not good , financial health is not good , and ability to make profit is not good , ...
| Quality Factors |
|
45% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 99 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 17.40 |
| PBV / Sector |
3.15 / 5.28
|
| Earning Per Share | -4.69 |
| PE / Sector |
N/A / 19.73
|
| PEG or PE/Growth / Sector |
N/A / 0.69
|
| Average 1M Daily Value |
24.44 M
GREAT
|
| Average 1W Daily Value |
34.49 M
GREAT
|
| Timing Factors |
|
71% |
| Financial Health |
|
43% |
| Ability to Make Profit |
|
47% |
| Return to Investors |
|
4% |
| Registration Details |
| Analyze Date | 2026-07-01 10:14:32 |
| Symbol | FTRE |
| Name | FORTREA HOLDINGS INC. |
| Sector | Healthcare >> Biotechnology |
| Market | NASDAQ |
| Listed Shares | 94.58 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 1,657.12 / 9,798.38 |
| News, Concensus, ... |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 8 Moore Drive, Durham, NC, United States, 27709
Phone: 877 495 0816
Website: https://www.fortrea.com
Employees: 14,000
Sector: Healthcare >> Biotechnology
Description: Fortrea Holdings Inc., a contract research organization, provides biopharmaceutical product and medical device development solutions to pharmaceutical, biotechnology, and medical device customers worldwide. It offers clinical pharmacology, such as clinical research units, external partnerships, project management, study design and monitoring, bioanalytics and biomarkers, pharmacokinetics, modeling and simulation, and biometrics; and clinical development, including phase I through IV clinical and real-world evidence studies, regulatory affairs, protocol design, operational planning, study and site start-up, patient recruitment, project management, comprehensive site and medical monitoring, data management and biostatistics, pharmacovigilance, medical writing, and mobile clinical services. The company also provides consulting services comprising product development and regulatory, market access and health economics, and outcomes research, as well as RWE services. Fortrea Holdings Inc. was incorporated in 2023 and is headquartered in Durham, North Carolina.
Analyst Ratings & Target Price
ME vs SECTOR Healthcare >> Biotechnology
Click a bubble to view stock details · Bubble size represents market capitalization share
